Chapel Hill, NC 27516
What is vegetarian fish oil? Source-Omega’s product, Pure One™, is used in their Omega-3 DHA Therapy™, formulated to provide a scientifically optimized ratio of DHA/EPA omega-3s, the same beneficial ingredients found in fish oil, but these come from a fresh algae oil source instead.
Chapel Hill, NC, October 14, 2009 --(PR.com)-- Source-Omega, a Chapel Hill-based company, announced today it has partnered with Veganlife Stockholm to offer its alternative to fish oil in Sweden.
The source of omega-3s in cold water fish is actually algae oil, a clean, sustainable resource used to make omega-3 DHA, the only omega-3 fatty acid proven to support a healthy brain, eyes and heart through every stage of life.
Rather than fish oil, Pure One™ is made with algae oil, which gives it attractiveness to those who prefer not to eat fish or fish oils. There is also no fishy taste, and there are no fishy "burps".
Pure One™ is made using only quality controlled processes and resources that are earth-friendly and self-contained to ensure that the product is free from contaminants.
“Pure One’s omega-3 ratio most closely matches the needs and composition of the human brain, an important fact for pregnant mothers to know about” said Pernilla Karlsson, Ph.D. Nutritionist, Toxicologist and Founder of Veganlife in Stockholm. “Pure One comes from a plant based source (algae), which means you can trust it more and you feel good about taking something so pure and helpful to the body and environment,” said Dr. Karlsson.
Dr. Karlsson also noted that Pure One™ is vegan-friendly, free from ocean pollutants, and is one of the most affordable DHA products on the market from any source.
DHA and EPA omega-3 essential fatty acids are found in human breast milk. Studies have shown that the algae DHA sources provide cognitive benefits for both the developing fetus and for an aging adult’s healthy brain, eyes and heart.
In addition, in subjects taking algae oil omega-3 DHA daily, significant improvements in plasma lipids are observed across 16 clinical studies that are supported by two reviews, one by Source-Omega’s Founder and one by Martek Biosciences Corporation [1,2].
“Data collected from Source-Omega consumer results also show therapeutic benefits with 1200 mg DHA + 40 mg EPA daily using Pure One. Pre-qualified subjects with high triglycerides (>200 mg/dl) volunteered for follow-up. Working with their doctors, the dosage provided 10% to 29% reduction in high triglyceride levels” reports Scott Doughman, Ph.D., a Lipidologist, Founder and Chief Scientific Officer at Source-Omega.
Dr. Doughman noted that the company results are consistent with clinical studies describing algae DHA providing 26% lower triglyceride levels consistently across the studies, when subjects are taking DHA dosages above 1 gram DHA per day.
Doughman also proposed the significance of these findings, saying “Perhaps the DHA level in prescription LOVAZA* by GSK is the most active component for lowering high triglyceride levels. Pure One is proudly prescription free. Our ongoing research and development at Source-Omega suggests that DHA is more effective than fish oil mixtures for lowering postprandial triglycerides, an emerging topic in the area of diabetic dyslipidemia, also a topic of our patent pending formulation and use status in the U.S.” [*LOVAZA (Omega-3 Acid Ethyl Ester) is a registered trademark of GlaxoSmithKline (GSK)]
Doughman concluded by suggesting an important role that Pure One™ plays in serving our planet’s future is by its use of only sustainable resources, thereby eliminating the need to “squeeze a fish” for the world's increasingly global omega-3 supplement needs.
About Source-Omega, LLC, Chapel Hill North Carolina, USA: Source-Omega is located near the Research Triangle Park, was founded by Dr Scott Doughman in 2007, for specializing in the manufacturing, branding, and globalization of algae oil nutritional products as an exclusive distributor of the brand name PURE ONE™- The Next Generation Plant Based Omega-3™ for their Omega-3 DHA Therapy™ and for clinics offering triglyceride lowering plasma lipids management programs or pregnancy, nursing and family care.
The company makes clinical DHA with EPA supplement products from algae oil for international and domestic distribution for pharmacy and store retail.
About Veganlife: Veganlife is a leading Scandinavian voice for vegan products in Sweden, also serving pregnant and nursing mothers in the region. With their sole-source license agreement with Source-Omega, Veganlife seeks to access about 1500 health shops and numerous clinics in Sweden alone, a health conscious country.
For more information on Source-Omega, visit www.source-omega.com. For more information on Veganlife Stockholm, visit www.veganlife.se or www.pureone.se.
 Doughman SD, Krupanidhi S, Sanjeevi CB. Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA.Curr Diabetes Rev. 2007 Aug;3(3):198-203. Review.
 Ryan AS, Keske MA, Hoffman JP, Nelson EB. Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors. American Journal of Therapeutics. 2009 Mar-Apr;16(2):183-92. Review.
Source-Omega, LLC announced today it will be presenting at the upcoming International Symposia on Bioinformatics for Biomedical and Ecological Applications in Prasanthi Nilayam, India. The conference is being held during February 20-21, 2009 at the renowned Sri Sathya Sai University and is organized by Biosciences Chair Professor Srirama Krupanidhi.
Chapel Hill, NC, February 20, 2009 --(PR.com)-- Source-Omega company Founder and Chief Scientist Scott Doughman, Ph.D. will present Saturday February 21, evidence that only one microalgae oil source for both docosahexaenoic acid (DHA) omega-3 and eicosapentaenoic acid (EPA) omega-3 qualifies as a replacement for medical fish oils, including the prescription form of synthetic fish oil.
Dr. Doughman is to discuss the importance of both DHA and EPA together for satisfying the regulatory guidance available for omega-3 oils regarding qualified heart health claims. He is also to discuss metabolic evidence that the naturally produced and scientifically optimized oil matches human clinical needs better than fish oils, particularly with respect to the intracellular fatty acid pathways known as the Kennedy cycle. “The ways our cells incorporate omega-3s are best matched by microalgae oil sources, plus there is no lingering fishy after effects, a major compliance issue facing fish oil omega-3 products” Doughman indicated.
The Indian subcontinent harbors the largest vegetarian preferred population in the world, with increasing fish oil prescriptions by doctors due to a lack of suitable alternatives. “Microalgae oil now provides a replacement for the same or better medical results, according to recent clinical trials” suggested Doughman.
The large, growing body of scientific evidence reproducibly demonstrates all ages benefit from an adequate DHA supply in the diet, with 90% of human omega-3 content incorporated as DHA. Scientific research highlights the primary importance of DHA alone for lowering triglycerides naturally. Clinical studies underway are to evaluate the role of DHA in decreasing the incidence of certain neurological disorders, including Alzheimer’s Disease. Leading experts around the world note that DHA is an important nutrient for health in humans, yet Americans and Indian populations have some of the lowest daily dietary intakes of DHA in the world.
Although suggested, but not finalized, one area of development is the apparent emergence of minimum percent daily value claims for DHA. In particular, omega-3 DHA serves as a primary building block for the heart, brain and eyes and DHA supports brain, eye and cardiovascular health throughout life.
Yet debates continue in the functional food market. According to The Wall Street Journal, the European Union is cracking down on foods that advertise health benefits without scientific backing. Even with scientific backing from clinical studies, the Food and Drug Administration in the United States gives notice that sufficient nutrient levels be present to support claims. “That is why I developed the first Omega-3 DHA Therapy method, a 3 month plan to properly eliminate possible DHA deficiency. The method is based on my research and the overwhelming evidence reported in human trials” said Doughman.
Concentrated omega-3 DHA dietary supplements made from microalgae oils or extracted from fish oils currently are the best way to get medical dosages of DHA at levels above 1 gram daily. DHA is found at low levels in fish and at high levels in certain microalgae oils.
Dr. Doughman points out that DHA is the only omega-3 needed in abundance as the other omega-3 forms are easily made by the body from DHA stores. Doughman received his PhD from the University of Wisconsin-Madison Department of Biochemistry and conducted National Institutes of Health funded postdoctoral research in Metabolism and Nutritional Biochemistry on polyunsaturated fatty acids at the University of North Carolina-Chapel Hill, Department of Nutrition. He has also served as a Visiting Faculty in Biosciences at the Sri Sathya Sai University since year 2000.
Source-Omega, LLC, Chapel Hill North Carolina, USA, is a manufacturer and distributor of private label microalgae products. The company is located near the Research Triangle Park in North Carolina and specializes in the branding, marketing and globalization of microalgae oil products. Source-Omega seeks to be a leading global distributor of microalgae oil under the brand name PURE ONE™ for better triglyceride lowering benefits and protection from cognitive decline, promoting health and wellness for every stage of life. The company manufactures DHA plus EPA supplement products as a sustainable vegetarian source of medical omega-3s. For more information on Source-Omega or Dr. Scott Doughman please visit http://www.source-omega.com.